Kairos Therapeutics - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $92,505.05 -6.08%
Ethereum $3,323.56 -4.95%
BNB $619.85 -7.17%
Optimism $2.15 -7.49%
Arbitrum $0.86 -6.09%
Solana $226.94 -10.59%
Polygon $0.52 -14.13%
Cosmos $7.73 -10.95%
Avalanche $39.47 -13.78%

Bitcoin $92,505.05 -6.08%
Ethereum $3,323.56 -4.95%
BNB $619.85 -7.17%
Optimism $2.15 -7.49%
Arbitrum $0.86 -6.09%
Solana $226.94 -10.59%
Polygon $0.52 -14.13%
Cosmos $7.73 -10.95%
Avalanche $39.47 -13.78%

Kairos Therapeutics

company

Summary

About

Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform.

51 - 100

Details

Industries: Biotechnology,Life Science,Medical
Founded date: Jan 1, 2013
Number Of Employee: 51 - 100
Operating Status: Close